Company intelligence / Profile preview

MedXL

Montreal, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

MedXL was a Canadian medical device manufacturer specializing in prefilled syringes for drug delivery and intravenous therapy. The company's product portfolio included Praxiject 0.9% sodium chloride injection USP prefilled syringes, CitraFlow sodium citrate prefilled syringes, and CitraFlow PLUS citrate-ethanol prefilled syringes with anticoagulant and antimicrobial properties.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on MedXL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedXL.

Explore the full profile